Cell-mediated immunity to chemically xenogenized tumors
- 31 January 1988
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 111 (2) , 365-378
- https://doi.org/10.1016/0008-8749(88)90100-1
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Analysis of protective and cytotoxic immune responses in vivo against metabolically inactivated and untreated cells of a mutagenized tumor line (requirements for tumor immunogenicity)Cellular Immunology, 1986
- Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell linesCellular Immunology, 1986
- There is more than one interleukin 1Immunology Today, 1986
- The role of L3T4 in recognition of Ia by a cytotoxic, H-2Dd-specific T cell hybridoma.The Journal of Experimental Medicine, 1984
- Identification of an I-J+ antigen-presenting cell required for third order suppressor cell activation.The Journal of Experimental Medicine, 1983
- MONOCLONAL ANTIBODIES TO MOUSE MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENSTransplantation, 1982
- Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells.The Journal of Experimental Medicine, 1982
- IN VITRO GENERATION OF PRIMARY CYTOTOXIC LYMPHOCYTES AGAINST L5178Y LEUKEMIA ANTIGENICALLY ALTERED BY 5-(3,3'-DIMETHYL-l-TRIAZENO)-IMIDAZOLE-4-CARBOXAMIDE IN VIVOTransplantation, 1979
- Ia antigen expression on human epidermal Langerhans cellsNature, 1977
- IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICEThe Journal of Experimental Medicine, 1974